Heliosupine N-oxide

CAS No. 31701-88-9

Heliosupine N-oxide( —— )

Catalog No. M32058 CAS No. 31701-88-9

Heliosupine N-oxide Description.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 731 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Heliosupine N-oxide
  • Note
    Research use only, not for human use.
  • Brief Description
    Heliosupine N-oxide Description.
  • Description
    Heliosupine N-oxide Description.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    31701-88-9
  • Formula Weight
    413.5
  • Molecular Formula
    C20H31NO8
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dynorphin A (1-13), ...

    Dynorphin A (1-13) amide is an endogenous opioid peptide that antagonizes morphine-induced analgesia.

  • CLIP 86-100

    This is amino acids 86 to 100 fragment of class II-associated invariant chain peptide called CLIP. The major histocompatibility complex class II molecule displays peptide fragments of foreign proteins to trigger a defensive reaction from the immune system. Before insertion of the foreign peptides into the binding groove, a place-holding peptide CLIP is removed. This is accomplished by the molecule DM, which is shown to increase the dissociation rate of a CLIP peptide from class II.

  • β-Aminoarteether

    β-Aminoarteether (SM934 free base), an orally active derivative of Artemisinin, serves a pivotal role in the research of inflammation and autoimmune disorders, including those related to lupus diseases.